Activated Clotting Time Testing Market Size to Reach US$ 777.12 Million by 2034
The healthcare industry continues to witness significant advancements in diagnostic and monitoring technologies, particularly in coagulation testing. Activated Clotting Time (ACT) testing is a critical point-of-care diagnostic procedure used to monitor anticoagulation therapy during cardiovascular surgeries, extracorporeal circulation procedures, catheterization, …